Neuros Medical Launches Altius System for Pain Relief
Neuros Medical Launches Altius System for Pain Relief
Neuros Medical is proud to announce a groundbreaking achievement in the field of chronic pain management with the commercial implantation of the Altius Direct Electrical Nerve Stimulation System. This innovative device offers a new hope for individuals suffering from chronic post-amputation pain, a condition affecting many amputees.
About the Altius System
The Altius System is recognized as the only FDA-approved device specifically designed to treat chronic post-amputation pain in lower limb amputees. Unlike traditional pain management solutions that often rely on opioids, the Altius System provides a non-opioid alternative. It employs direct electrical nerve stimulation, effectively blocking pain signals from reaching the brain and offering patients a means to obtain relief on-demand.
Significant Milestone in Pain Treatment
In a recent procedure at a leading hospital, the first patient in the U.S. received the Altius implant, a moment celebrated by the team at Neuros Medical. This achievement marks a pivotal moment in addressing a pressing medical need, as many individuals living with limb loss face inadequate treatment options. With the Altius System, a new chapter opens for those who have struggled with ineffective conventional therapies.
A Comprehensive Approach to Pain Management
The Altius System operates with a patient-controlled mechanism, allowing users to initiate treatment sessions as necessary. In each session, a unique pulse generator and nerve cuff electrode work together to inhibit painful signals from the affected nerves. This innovative approach has the potential to transform the quality of life for many amputees suffering from chronic pain.
Statistics indicate that over two million individuals in the U.S. live with major limb loss, and approximately 80% may experience some form of chronic post-amputation pain. By providing a targeted solution, the Altius System opens the door to effective pain relief for this population.
Neuros Medical's Commitment to Patients
Neuros Medical is more than just a medical device company; it's a heartfelt mission driven by a commitment to enhancing the lives of those with chronic pain. The company is dedicated to exploring new horizons in neuromodulation therapies, offering hope to patients who have limited options for managing their pain.
Conclusion
By launching the Altius System, Neuros Medical showcases its unwavering dedication to innovation in healthcare. With a visionary approach to pain management, the company is set to change the landscape for treating chronic post-amputation pain. Collaborating with esteemed healthcare institutions, Neuros Medical fosters a commitment to excellence and responsibility in offering solutions to complex medical needs.
Frequently Asked Questions
What is the Altius System?
The Altius System is a revolutionary FDA-approved device designed to alleviate chronic post-amputation pain through direct electrical nerve stimulation.
How does the Altius System work?
This system uses a patient-controlled mechanism to block painful nerve signals, providing on-demand relief from chronic pain without opioids.
Who can benefit from the Altius System?
Individuals who have undergone lower limb amputations and suffer from chronic pain may benefit greatly from the Altius System.
Is the Altius System safe?
The Altius System is FDA-approved, indicating rigorous safety evaluations and adherence to medical standards for device efficacy.
Where can I learn more about Neuros Medical and the Altius System?
For comprehensive information, please visit the official Neuros Medical website, where further details regarding the Altius System are available.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
